Pramlintide
Shop PramlintideAlso called: Pramlintide acetate, Pramlintide + Insulin Glargine, SYMLIN (pramlintide acetate) with Insulin
Pramlintide is a man-made copy of a natural body chemical called amylin. Amylin is made by the same cells in the pancreas that make insulin. The man-made version is sold under the brand name Symlin. Doctors prescribe it for people with diabetes who already use insulin at mealtimes.
Pramlintide helps lower blood sugar after meals. It works by slowing down how fast food leaves the stomach, so sugar from food enters the blood more slowly. It also helps people feel full, which can lead to eating less and losing some weight. Studies show it does not lower blood sugar when sugar is given directly into a vein, which shows its effect is tied to how the gut handles food.
Pramlintide was approved by the FDA in 2005. It is given as a small shot under the skin, usually about 30 micrograms at a time. It leaves the body quickly, within about an hour. The main caution is that it can cause low blood sugar if not timed right with meals and insulin. It is expensive and can be hard to get, which limits how many people use it.
Benefits
What Pramlintide Helps With
The benefits people report — backed by research.
Weight management (2)
Cancer / tumor (2)
Glycemic & metabolic (1)
More reported benefits (1)
Free: The Peptide Stack Cheat-Sheet
You just read the research on Pramlintide. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
How People Use It
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
- Varies (Requires Titration) 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Known Side Effects
Adverse effects reported in the research and by community use.
- Nausea / VomitingModerate 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pubmed.ncbi.nlm.nih.gov
- Immune system attacks on normal organs and tissuesSevere 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ synapse.patsnap.com
- GI Symptoms (Gas, Diarrhea)Moderate 72/100Rated 72/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pubmed.ncbi.nlm.nih.gov
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Get Pramlintide
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Research Citations (6)
Every claim above traces back to a source you can check — here are 6 of them.
- Source
Therapies for diabetes: pramlintide and exenatide.
2007 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Pramlintide in the treatment of diabetes mellitus.
2008 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.
2004 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
2005 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Amyloidogenesis of the amylin analogue pramlintide.
2016 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
Timeline
History & Milestones
Key moments in Pramlintide’s research and regulatory timeline — sourced and dated.
- Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's DiseasePublicationJan 1, 2018Related:Pramlintide
- Pramlintide in the treatment of diabetes mellitusPublicationJun 15, 2007Related:Pramlintide
- Pramlintide in the treatment of type 1 and type 2 diabetes mellitusPublicationOct 1, 2005Related:Pramlintide
- Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patientsPublicationApr 1, 2004Related:Pramlintide
Wondering how Pramlintide pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →